Read + Share
Amedeo Smart
Independent Medical Education
Garciaz S, Dumas PY, Bertoli S, Sallman DA, et al. Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment. Am J Hematol 2024 Jun 20. doi: 10.1002/ajh.27417.PMID: 38899566
Email
LinkedIn
Privacy Policy